These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8420221)

  • 21. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P; Lenz FA; Chase TN
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract]   [Full Text] [Related]  

  • 22. Origin of chorea-ballism and multisystem degeneration: pathophysiological implications.
    Obeso JA; Luquin MR; Herrero MT; Guridi J
    Mov Disord; 1993; 8(1):123-4. PubMed ID: 8419800
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine and basal ganglia.
    Hikosaka O
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):511. PubMed ID: 1762258
    [No Abstract]   [Full Text] [Related]  

  • 24. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.
    Benazzouz A; Boraud T; Féger J; Burbaud P; Bioulac B; Gross C
    Mov Disord; 1996 Nov; 11(6):627-32. PubMed ID: 8914087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the globus pallidus on hippocampal epilepsy in the cat].
    Sabatino M; La Grutta V; Gravante G; La Grutta G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):93-7. PubMed ID: 2983745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
    Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
    Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of rhythmic photic stimulation on monkeys with hypokinesis of post-encephalitic origin].
    Danilov IV; Kudriavtseva NN
    Fiziol Zh SSSR Im I M Sechenova; 1972 Apr; 58(4):511-6. PubMed ID: 4623791
    [No Abstract]   [Full Text] [Related]  

  • 28. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
    Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of L-dopa-induced dyskinesias.
    Bédard PJ; Blanchet PJ; Lévesque D; Soghomonian JJ; Grondin R; Morissette M; Goulet M; Calon F; Falardeau P; Gomez-Mancilla B; Doucet JP; Robertson GS; DiPaolo T
    Mov Disord; 1999; 14 Suppl 1():4-8. PubMed ID: 10493397
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine systems in human immunodeficiency virus-associated dementia.
    Lopez OL; Smith G; Meltzer CC; Becker JT
    Neuropsychiatry Neuropsychol Behav Neurol; 1999 Jul; 12(3):184-92. PubMed ID: 10456803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decorticate versus decerebrate rigidity in subhuman primates and man.
    Carey JH; Crosby EC; Schnitzlein HN
    Neurology; 1970 Apr; 20(4):396-7. PubMed ID: 4998068
    [No Abstract]   [Full Text] [Related]  

  • 32. [Movement disorders and basal ganglia function].
    Dietrichs E
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.
    Wichmann T; Kliem MA; DeLong MR
    Exp Neurol; 2001 Feb; 167(2):410-24. PubMed ID: 11161630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.
    Stephenson DT; Li Q; Simmons C; Connell MA; Meglasson MD; Merchant K; Emborg ME
    Neurobiol Dis; 2005 Nov; 20(2):347-59. PubMed ID: 15882945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological studies of information processing in the normal and Parkinsonian basal ganglia: pallidal activity in Go/No-Go task and following MPTP treatment.
    Morris G; Hershkovitz Y; Raz A; Nevet A; Bergman H
    Prog Brain Res; 2005; 147():285-93. PubMed ID: 15581713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary origin of extrapyramidal disorders in drug-treated mental patients, its significance, and the role of neuromelanin.
    Forrest FM
    Adv Biochem Psychopharmacol; 1974; 9(0):255-68. PubMed ID: 4151764
    [No Abstract]   [Full Text] [Related]  

  • 37. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia.
    Nevet A; Morris G; Saban G; Fainstein N; Bergman H
    J Neurophysiol; 2004 Oct; 92(4):1973-81. PubMed ID: 15115785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
    Herrero MT; Levy R; Ruberg M; Javoy-Agid F; Luquin MR; Agid Y; Hirsch EC; Obeso JA
    Adv Neurol; 1996; 69():209-16. PubMed ID: 8615130
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse.
    Engler B; Freiman I; Urbanski M; Szabo B
    J Pharmacol Exp Ther; 2006 Feb; 316(2):608-17. PubMed ID: 16214880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.